The most recent trading session ended with Merck (MRK) standing at $97.45, reflecting a -0.5% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500's daily ...

The daughter of former President John F. Kennedy is speaking out against Health and Human Services Secretary designate Robert F. Kennedy Jr., lambasting her cousin as a “predator” with “dangerous” ...

Co., Inc. (NYSE:MRK), a global healthcare leader, declared on Monday a quarterly dividend and a substantial stock repurchase ...

Robert F. Kennedy Jr. has built his fortune and reputation on disparaging the government scientists and institutions he's now ...

Merck (MRK) announced that the board of directors has declared a quarterly dividend of 81c per share of the company’s common stock for the ...

We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to ...

Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $97.94 which represents a slight increase of $2.39 or 2.50% from the prior close of $95.55. The stock opened at $96.63 and touched a ...

RFK Jr. played a lead role in building an case against Merck's HPV vaccine and could profit from the lawsuit alleging fraud, ...

Merck & Co. Inc. closed 27.25% short of its 52-week high of $134.63, which the company reached on June 25th.

We recently published a list of 12 Best Depressed Stocks to Invest in Now. In this article, we are going to take a look at ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for belzutifan for the treatment of adult and pediatric patients aged 12 years and ...